SAM, Linklaters, JSA Act On Biocon’s $460 Million QIP Biopharamaceuticals January 19, 2026 Capital Markets
SAM, JSA Advised On Tonbo Imaging’s Proposed IPO Manufacturing January 5, 2026 Capital Markets – Equity
SAM, JSA Advised On CORONA Remedies’ ₹655 Cr IPO Pharmaceuticals December 25, 2025 Capital Markets – Equity
AZB, Duane Morris & Selvam, JSA Advised On GK Energy’s IPO Renewable Energy October 3, 2025 Capital Markets – Equity
JSA Advised Biocon Limited In Raising ₹4500 Cr Through A QIP Biopharamaceuticals June 27, 2025 Capital Markets – Equity
JSA Advised BRLMs On Prozeal Green Energy’s Proposed IPO Renewable Energy April 8, 2025 Capital Markets – Equity
